These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20022897)

  • 21. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
    Handel A; Longini IM; Antia R
    J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of seasonal and pandemic influenza: prospects for control.
    Monto AS
    Clin Infect Dis; 2009 Jan; 48 Suppl 1():S20-5. PubMed ID: 19067611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza pandemic preparedness in France: modelling the impact of interventions.
    Doyle A; Bonmarin I; Lévy-Bruhl D; Le Strat Y; Desenclos JC
    J Epidemiol Community Health; 2006 May; 60(5):399-404. PubMed ID: 16614329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential benefits and limitations of various strategies to mitigate the impact of an influenza pandemic.
    Oshitani H
    J Infect Chemother; 2006 Aug; 12(4):167-71. PubMed ID: 16944252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic.
    Hsu EB; Millin MG
    Biosecur Bioterror; 2008 Jun; 6(2):171-8. PubMed ID: 18563994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antivirals in the management of an influenza pandemic.
    Harrod ME; Emery S; Dwyer DE
    Med J Aust; 2006 Nov; 185(S10):S58-61. PubMed ID: 17115954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
    Chawla R; Sharma RK; Bhardwaj JR
    Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious disease: can we avert a lethal flu pandemic?
    May RM
    Curr Biol; 2005 Nov; 15(22):R922-4. PubMed ID: 16303549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.
    McCaw JM; McVernon J
    Math Biosci; 2007 Oct; 209(2):336-60. PubMed ID: 17416393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conceptional considerations for a German influenza pandemic preparedness plan.
    Fock R; Bergmann H; Bussmann H; Fell G; Finke EJ; Koch U; Niedrig M; Peters M; Scholz D; Wirtz A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):191-5. PubMed ID: 12458359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple models for containment of a pandemic.
    Arino J; Brauer F; van den Driessche P; Watmough J; Wu J
    J R Soc Interface; 2006 Jun; 3(8):453-7. PubMed ID: 16849273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scenarios of diffusion and control of an influenza pandemic in Italy.
    Rizzo C; Lunelli A; Pugliese A; Bella A; Manfredi P; Tomba GS; Iannelli M; Ciofi degli Atti ML
    Epidemiol Infect; 2008 Dec; 136(12):1650-7. PubMed ID: 18272019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prophylactic Effect of Anti-influenza Agents for an Influenza Outbreak in a University Hospital.
    Hagihara M; Kato Y; Kurumiya A; Takahashi T; Sakata M; Kato H; Sakanashi D; Yamada A; Suematsu H; Hirai J; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    Intern Med; 2018; 57(4):497-501. PubMed ID: 29445061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel strategies for prevention and treatment of influenza.
    Kandel R; Hartshorn KL
    Expert Opin Ther Targets; 2005 Feb; 9(1):1-22. PubMed ID: 15757479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?
    Pappaioanou M
    Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):287-300. PubMed ID: 19318178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis.
    Ye M; Jacobs A; Khan MN; Jaipaul J; Oda J; Johnson M; Doroshenko A
    BMJ Open; 2016 Jul; 6(7):e011686. PubMed ID: 27381211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies.
    Zachreson C; Fair KM; Harding N; Prokopenko M
    J R Soc Interface; 2020 Apr; 17(165):20190728. PubMed ID: 32316882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The evaluation of policies on 2009 influenza pandemic in Korea].
    Choi WS; Kim WJ; Cheong HJ
    J Prev Med Public Health; 2010 Mar; 43(2):105-8. PubMed ID: 20383042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies.
    Lee VJ; Lye DC; Wilder-Smith A
    BMC Med; 2009 Dec; 7():76. PubMed ID: 20003249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.